Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and nine months ended December 31, 2019. According to the update, the company’s unaudited condensed interim consolidated financial statements as well as its management’s discussion and analysis (“MD&A”) for Q3 2020 are available under … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Reports Q3 Fiscal Year 2020 Financial Results, Provides Corporate Update”
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly owned subsidiary of the company, subscribed for 2,380,952 units of James E. Wagner Cultivation Corp. (“JWC”) (TSX.V: JWCA) (OTCQX: JWCAF) at a price of $0.21 each for total consideration of approximately $500,000 in … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Files Early Warning Report Regarding James E. Wagner Cultivation Corp. (TSX.V: JWCA) (OTCQX: JWCAF) Investment”
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly-owned subsidiary of the company, has amended the terms of its recent US$10 million loan to TerrAscend Canada Inc., a wholly‑owned subsidiary of TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF). The loan, announced October 2, … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Subsidiary Modifies TerrAscend Canada Loan Terms”
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning provided an update regarding recent announcements from its portfolio companies High Beauty, Inc., TerrAscend Corp. (CSE: TER), YSS Corp. (TSX.V: YSS) and James E. Wagner Cultivation Corp. (TSX.V: JWC) (OTCQX: JWCAF). Per the update, High Beauty will remember 2019 as … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Companies”
Canopy Rivers (TSX: RIV) (OTC: CNPOF) portfolio company BioLumic Ltd. has received New Zealand Ministry of Health approval to apply its proprietary ultraviolet (“UV”) light technology to medical cannabis. According to the update, BioLumic’s approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%. This approval marks the … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) BioLumic Receives Approval to Apply Proprietary UV Light Technology to Medical Cannabis”
CURE Pharmaceutical (OTCQB: CURR), an innovative drug delivery and development company, recently announced the appointment of John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to Cure Pharmaceutical, most recently serving as chairman of the Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) board of directors. … Continue reading “NetworkNewsBreaks – CURE Pharmaceutical (CURR) Appoints Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) Chairman, John K. Bell, to Board of Directors”
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) today announced the appointment of David Klein as the company’s chief executive officer, effective January 14, 2020. Klein served in a number of senior leadership capacities over the past 14 years at Constellation Brands and brings a wealth of expertise to this role. His capabilities include extensive CPG … Continue reading “NetworkNewsBreaks – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) Appoints New Chief Executive Officer David Klein”
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant and sports business executive Rich Kleiman. According to the update, Thirty Five Ventures will collaborate with Canopy Rivers as it … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures”
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the broadening of operations of its portfolio companies as they position for success in the growing market. The update highlighted several enhancements and expansions, including one company’s launch of a data intelligence tool to assist retailers in tracking sales metrics … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Portfolio Companies Expand for Success in the Growing Market”
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning released its financial results for the three and six months ended September 30, 2019. The company’s unaudited condensed interim consolidated financial statements for Q2 2020, as well as its management’s discussion and analysis (“MD&A”) for Q2 2020, are available under … Continue reading “NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update”
